McKesson (NYSE:MCK) Updates FY25 Earnings Guidance

McKesson (NYSE:MCK) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $31.25-$32.05 for the period, compared to the consensus earnings per share estimate of $31.09. The company issued revenue guidance of $355.35-$361.53 billion, compared to the consensus revenue estimate of $341.05 billion.

Wall Street Analyst Weigh In

A number of research analysts have commented on MCK shares. Evercore ISI lifted their target price on McKesson from $590.00 to $600.00 and gave the company an outperform rating in a research note on Wednesday. SVB Leerink began coverage on McKesson in a report on Monday, February 26th. They set an outperform rating and a $600.00 price objective for the company. TD Cowen lifted their price target on shares of McKesson from $563.00 to $652.00 and gave the stock a buy rating in a research report on Wednesday. UBS Group increased their price objective on shares of McKesson from $620.00 to $630.00 and gave the company a buy rating in a report on Wednesday. Finally, Leerink Partnrs reaffirmed an outperform rating on shares of McKesson in a report on Monday, February 26th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of Moderate Buy and a consensus price target of $569.86.

McKesson Stock Down 0.5 %

MCK traded down $2.53 during trading hours on Wednesday, hitting $543.22. 1,378,614 shares of the company’s stock were exchanged, compared to its average volume of 713,234. The stock’s 50-day moving average is $531.17 and its two-hundred day moving average is $493.81. McKesson has a 1-year low of $373.28 and a 1-year high of $566.01. The stock has a market cap of $71.38 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 1.41 and a beta of 0.45.

McKesson (NYSE:MCK) last released its earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.34 by ($0.16). The company had revenue of $76.36 billion for the quarter, compared to the consensus estimate of $79.32 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The business’s revenue was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.19 EPS. On average, equities research analysts anticipate that McKesson will post 27.59 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a yield of 0.46%. The ex-dividend date is Friday, May 31st. McKesson’s dividend payout ratio (DPR) is currently 11.24%.

Insider Activity

In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the transaction, the chief executive officer now owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 186 shares of McKesson stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at $749,456. The disclosure for this sale can be found here. Insiders own 0.21% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.